A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 26 400 KRW -3.47%
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
ABL Bio Inc

Wall Street analysts forecast ABL Bio Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 50 660 KRW with a low forecast of 37 370 KRW and a high forecast of 63 000 KRW.

Lowest
Price Target
37 370 KRW
42% Upside
Average
Price Target
50 660 KRW
92% Upside
Highest
Price Target
63 000 KRW
139% Upside
ABL Bio Inc Competitors:
Price Targets
KRRO
Korro Bio Inc
213% Upside
AMGN
Amgen Inc
28% Upside
EXAI
Exscientia PLC
13% Upside
CCCC
C4 Therapeutics Inc
278% Upside
SIGHT
Gensight Biologics SA
40% Upside
MRNA
Moderna Inc
98% Upside
PTGX
Protagonist Therapeutics Inc
39% Upside
ALGS
Aligos Therapeutics Inc
73% Upside

Revenue
Forecast

Revenue Estimate
ABL Bio Inc

For the last 6 years the compound annual growth rate for ABL Bio Inc's revenue is 212%. The projected CAGR for the next 3 years is -11%.

212%
Past Growth
-11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ABL Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
ABL Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABL Bio Inc's stock price target?
Price Target
50 660 KRW

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 50 660 KRW with a low forecast of 37 370 KRW and a high forecast of 63 000 KRW.

What is ABL Bio Inc's Revenue forecast?
Projected CAGR
-11%

For the last 6 years the compound annual growth rate for ABL Bio Inc's revenue is 212%. The projected CAGR for the next 3 years is -11%.

Back to Top